SEC Form 4/A · accession 0001716950-18-000010
APPLIED GENETIC TECHNOLOGIES CORP · AGTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Matthew Feinsod
Officer — Interim Chief Medical Officer
Period of report
Jan 11, 2018
Accepted (ET)
Apr 6, 2018 · 8:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001273636
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 11, 2018 | A | 2,000 | $0.00 | A | 26,253 | D | |
| Common StockF3 | Jan 11, 2018 | F | 791 | $4.30 | D | 25,462 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The common stock vested immediately upon grant.
- F2Such number has been updated to reflect a Form 4 filed on the date hereof that reported the number of shares withheld in connection with the reporting person's tax obligation as a result of the vesting of a restricted stock award on December 11, 2017.
- F3This Form 4/A amends the Form 4 previously filed on January 16, 2018 to correct the number of shares withheld in connection with the reporting person's tax obligation as a result of the fully vested stock award.